| 1 | A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse. (Lin X, Xu Z, Carey L, Romero J, Makriyannis A, Hillard CJ, Ruggiero E, Dockum M, Houk G, Mackie K, Albrecht PJ, Rice FL, Hohmann AG) Pain 2022 May 01;163(5):834-851 27 Citations |
| 1 | The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease. (Yu H, Liu X, Chen B, Vickstrom CR, Friedman V, Kelly TJ, Bai X, Zhao L, Hillard CJ, Liu QS) Cells 2021 Dec 16;10(12) 37 Citations |
| 1 | Wnt modulating agents inhibit human cytomegalovirus replication. (Kapoor A, He R, Venkatadri R, Forman M, Arav-Boger R) Antimicrob Agents Chemother 2013 Jun;57(6):2761-7 50 Citations |
| 1 | Kitlow stem cells cause resistance to Kit/platelet-derived growth factor alpha inhibitors in murine gastrointestinal stromal tumors. (Bardsley MR, Horváth VJ, Asuzu DT, Lorincz A, Redelman D, Hayashi Y, Popko LN, Young DL, Lomberk GA, Urrutia RA, Farrugia G, Rubin BP, Ordog T) Gastroenterology 2010 Sep;139(3):942-52 105 Citations |
| 1 | First evidence of Okadaic acid acyl-derivative and Dinophysistoxin-3 in mussel samples collected in Chiloe Island, Southern Chile. (García C, Pruzzo M, Rodríguez-Unda N, Contreras C, Lagos N) J Toxicol Sci 2010 Jun;35(3):335-44 22 Citations |
| 1 | Synthesis of cyclopropanes via organoiron methodology: preparation of the C9-C16 alkenylcyclopropane segment of ambruticin. (Lukesh JM, Donaldson WA) Chem Commun (Camb) 2005 Jan 07(1):110-2 23 Citations |
| 1 | Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. (Miura H, Wachtel RE, Loberiza FR Jr, Saito T, Miura M, Nicolosi AC, Gutterman DD) Circ Res 2003 Feb 07;92(2):151-8 157 Citations |
| 1 | High-salt diet impairs vascular relaxation mechanisms in rat middle cerebral arteries. (Lombard JH, Sylvester FA, Phillips SA, Frisbee JC) Am J Physiol Heart Circ Physiol 2003 Apr;284(4):H1124-33 64 Citations |
| 1 | Microbial transformation of kawain and methysticin. (Abourashed EA, Khan IA) Chem Pharm Bull (Tokyo) 2000 Dec;48(12):1996-8 26 Citations |
| 1 | Cardioprotective actions of potassium channel openers. (Auchampach JA, Maruyama M, Gross GJ) Eur Heart J 1994 Aug;15 Suppl C:89-94 23 Citations |
| 1 | The ATP-regulated potassium channel in ischemia-reperfusion injury. (Gross GJ, Yao Z, Pieper GM, Auchampach JA) Ann N Y Acad Sci 1994 Jun 17;723:71-81 24 Citations |
| 1 | Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs. (Auchampach JA, Gross GJ) Eur Heart J 1993 Jul;14 Suppl B:10-5 30 Citations |
| 1 | Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. (Auchampach JA, Maruyama M, Cavero I, Gross GJ) Circulation 1992 Jul;86(1):311-9 178 Citations |
| 1 | The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. (Auchampach JA, Maruyama M, Cavero I, Gross GJ) J Pharmacol Exp Ther 1991 Dec;259(3):961-7 127 Citations |
© 2026 Clinical & Translational Science Institute